Exploration Medical Capability (ExMC) Strategy for Assuring Pharmaceutical Stability During Exploration Spaceflight
Explore the source record for details and available documents.
John F. Reichard↗
Engineering topics
Benjamin D. Easter
Publications and source records attributed to Benjamin D. Easter.
Evidence Report: Risk of Ineffective or Toxic Medication During Long-Duration Exploration Spaceflight
The scope of this report is limited to evaluating drug stability with respect to spaceflight. The effects of spaceflight on drug pharmacokinetics (PK) or drug pharmacodynamics (PD) are not addressed in this report: these topics will be reviewed in future reports. This is the first report of the available evidence pertaining to the chemical and physical stability of drugs in the context of drug impurity, drug repackaging, and exposure to ionizing space radiation. Previous studies are discussed within this report and, where possible, the data are interpreted and contextualized with regards to drug stability.
John F. Reichard↗
The Exploration Crew Medical Officer of the Future
Explore the source record for details and available documents.
Exploration↗